|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanase A, Colita A, Ianosi G, Neagoe D,
Branisteanu DE, Calina D, Docea AO, Tsatsakis A and Ianosi SL: Rare
case of disseminated fusariosis in a young patient with graft vs.
host disease following an allogeneic transplant. Exp Ther Med.
12:2078–2082. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ungureanu A, Zlatian O, Mitroi G, Drocaş
A, Ţîrcă T, Călina D, Dehelean C, Docea AO, Izotov BN, Rakitskii
VN, et al: Staphylococcus aureus colonisation in patients from a
primary regional hospital. Mol Med Rep. 16:8771–8780. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calina D, Rosu L, Roșu AF, Ianoşi G,
Ianoşi S, Zlatian O, Mitruț R, Docea AO, Rogoveanu O, Mitruț P, et
al: Etiological diagnosis and pharmacotherapeutic management of
parapneumonic pleurisy. Farmacia. 64:946–952. 2016.
|
|
7
|
Lemjabbar-Alaoui H, Hassan OU, Yang YW and
Buchanan P: Lung cancer: Biology and treatment options. Biochim
Biophys Acta. 1856:189–210. 2015.PubMed/NCBI
|
|
8
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Knight SB, Crosbie PA, Balata H, Chudziak
J, Hussell T and Dive C: Progress and prospects of early detection
in lung cancer. Open Biol. 7:1700702017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Daphedar A and Taranath TC:
Characterization and cytotoxic effect of biogenic silver
nanoparticles on mitotic chromosomes of drimia polyantha (Blatt.
& McCann) stearn. Toxicol Rep. 5:910–918. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sani TA, Mohammadpour E, Mohammadi A,
Memariani T, Yazd MV, Ramin R, Daniela C, Anca OD, Marina G, Etemad
L and Shahsavand S: Cytotoxic and apoptogenic properties of
Dracocephalum kotschyi aerial part different fractions on calu-6
and mehr-80 lung cancer cell lines. Farmacia. 65:189–199. 2017.
|
|
12
|
Saab AM, Guerrini A, Sacchetti G, Maietti
S, Zeino M, Arend J, Gambari R, Bernardi F and Efferth T:
Phytochemical analysis and cytotoxicity towards multidrug-resistant
leukemia cells of essential oils derived from lebanese medicinal
plants. Planta Med. 78:1927–1931. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shao H, Jing K, Mahmoud E, Huang H, Fang X
and Yu C: Apigenin sensitizes colon cancer cells to antitumor
activity of ABT-263. Mol Cancer Ther. 12:2640–2650. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng S, Kapur A, Patankar MS and Xiong MP:
Formulation, characterization, and antitumor properties of trans-
and cis-citral in the 4T1 breast cancer xenograft mouse model.
Pharm Res. 32:2548–2558. 2015.PubMed/NCBI
|
|
15
|
Forde PM, Brahmer JR and Kelly RJ: New
strategies in lung cancer: Epigenetic therapy for non-small cell
lung cancer. Clin Cancer Res. 20:2244–2248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calle AS, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun H, Huang Z, Sheng W and Xu MD:
Emerging roles of long non-coding RNAs in tumor metabolism. J
Hematol Oncol. 11:1062018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun M, Gadad SS, Kim DS and Kraus WL:
Discovery, annotation, and functional analysis of long noncoding
rnas controlling cell-cycle gene expression and proliferation in
breast cancer cells. Mol Cell. 59:698–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chakravarty D, Sboner A, Nair SS,
Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K,
Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA
NEAT1 is a critical modulator of prostate cancer. Nat Commun.
5:53832014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
She K, Huang J, Zhou H, Huang T, Chen G
and He J: lncRNA-SNHG7 promotes the proliferation, migration and
invasion and inhibits apoptosis of lung cancer cells by enhancing
the FAIM2 expression. Oncol Rep. 36:2673–2680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J
and Sung JJ: MicroRNA dysregulation in gastric cancer: A new player
enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin C and Yang L: Long noncoding RNA in
Cancer: Wiring signaling circuitry. Trends Cell Biol. 28:287–301.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang C, Wang C, Jia Z, Tong W, Liu D, He
C, Huang X and Xu W: Differentially expressed mRNAs, lncRNAs, and
miRNAs with associated co-expression and ceRNA networks in
ankylosing spondylitis. Oncotarget. 8:113543–113557. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fan CN, Ma L and Liu N: Systematic
analysis of lncRNA-miRNA-mRNA competing endogenous RNA network
identifies four-lncRNA signature as a prognostic biomarker for
breast cancer. J Transl Med. 16:2642018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cong Z, Diao Y, Xu Y, Li X, Jiang Z, Shao
C, Ji S, Shen Y, De W and Qiang Y: Long non-coding RNA linc00665
promotes lung adenocarcinoma progression and functions as ceRNA to
regulate AKR1B10-ERK signaling by sponging miR-98. Cell Death Dis.
10:842019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo T, Li J, Zhang L, Hou W, Wang R, Zhang
J and Gao P: Multidimensional communication of microRNAs and long
non-coding RNAs in lung cancer. J Cancer Res Clin Oncol. 145:31–48.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu S, Yan G, Zhang J and Yu L: Knockdown
of long noncoding RNA (lncRNA) metastasis-associated lung
adenocarcinoma transcript 1 (MALAT1) inhibits proliferation,
migration, and invasion and promotes apoptosis by targeting miR-124
in retinoblastoma. Oncol Res. 26:581–591. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang D and Hu Y: Long non-coding RNA PVT1
competitively binds microRNA-424-5p to regulate CARM1 in
radiosensitivity of non-small-cell lung cancer. Mol Ther Nucleic
Acids. 16:130–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang X, Zhang W, Cheng SQ and Yang RL:
High expression of lncRNA GACAT3 inhibits invasion and metastasis
of non-small cell lung cancer to enhance the effect of
radiotherapy. Eur Rev Med Pharmacol Sci. 22:1315–1322.
2018.PubMed/NCBI
|
|
31
|
Yang J, Du YM and Li B: LncRNA BX357664
inhibits the proliferation and invasion of non-small cell lung
cancer cells. Eur Rev Med Pharmacol Sci. 23:660–669.
2019.PubMed/NCBI
|
|
32
|
Tian Y, Yu M, Sun L, Liu L, Huo S, Shang
W, Sheng S, Wang J, Sun J, Hu Q, et al: Long noncoding RNA00887
reduces the invasion and metastasis of nonsmall cell lung cancer by
causing the degradation of miRNAs. Oncol Rep. 42:1173–1182.
2019.PubMed/NCBI
|
|
33
|
Ali MM, Akhade VS, Kosalai ST, Subhash S,
Statello L, Meryet-Figuiere M, Abrahamsson J, Mondal T and Kanduri
C: PAN-Cancer analysis of S-phase enriched lncRNAs identifies
oncogenic drivers and biomarkers. Nat Commun. 9:8832018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JH, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 world health organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kartha RV and Subramanian S: Competing
endogenous RNAs (ceRNAs): New entrants to the intricacies of gene
regulation. Front Genet. 5:82014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Paraskevopoulou MD, Vlachos IS, Karagkouni
D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P,
Floros E, Dalamagas T and Hatzigeorgiou AG: DIANA-LncBase v2:
Indexing microRNA targets on non-coding transcripts. Nucleic Acids
Res. 44:D231–D238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Balas MM and Johnson AM: Exploring the
mechanisms behind long noncoding RNAs and cancer. Noncoding RNA
Res. 3:108–117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jin Y, Feng SJ, Qiu S, Shao N and Zheng
JH: LncRNA MALAT1 promotes proliferation and metastasis in
epithelial ovarian cancer via the PI3K-AKT pathway. Eur Rev Med
Pharmacol Sci. 21:3176–3184. 2017.PubMed/NCBI
|
|
41
|
Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han
Z, Sui H, Tang Y, Wang Y, Liu N, et al: Long non-coding RNA MALAT1
promotes tumour growth and metastasis in colorectal cancer through
binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2
complex. Br J Cancer. 111:736–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Celestino R, Nome T, Pestana A, Hoff AM,
Gonçalves AP, Pereira L, Cavadas B, Eloy C, Bjøro T,
Sobrinho-Simões M, et al: CRABP1, C1QL1 and LCN2 are biomarkers of
differentiated thyroid carcinoma, and predict extrathyroidal
extension. BMC Cancer. 18:682018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu H, Yu J, Zhu H, Guo Y and Feng S:
Identification of key lncRNAs in colorectal cancer progression
based on associated protein-protein interaction analysis. World J
Surg Oncol. 15:1532017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
You X, Zhao Y, Sui J, Shi X, Sun Y, Xu J,
Liang G, Xu Q and Yao Y: Integrated analysis of long noncoding RNA
interactions reveals the potential role in progression of human
papillary thyroid cancer. Cancer Med. 7:5394–5410. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Deng M, Qin Y, Chen X, Wang Q and Wang J:
MiR-206 inhibits proliferation, migration, and invasion of gastric
cancer cells by targeting the MUC1 gene. Onco Targets Ther.
12:849–859. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun P, Sun D, Wang X, Liu T, Ma Z and Duan
L: MiR-206 is an independent prognostic factor and inhibits tumor
invasion and migration in colorectal cancer. Cancer Biomark.
15:391–396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fu Y, Shao ZM, He QZ, Jiang BQ, Wu Y and
Zhuang ZG: Hsa-MiR-206 represses the proliferation and invasion of
breast cancer cells by targeting Cx43. Eur Rev Med Pharmacol Sci.
19:2091–2104. 2015.PubMed/NCBI
|
|
49
|
Zhang T, Liu M, Wang C, Lin C, Sun Y and
Jin D: Down-Regulation of miR-206 promotes proliferation and
invasion of laryngeal cancer by regulating VEGF expression.
Anticancer Res. 31:3859–3863. 2011.PubMed/NCBI
|
|
50
|
Samaeekia R, Adorno-Cruz V, Bockhorn J,
Chang YF, Huang S, Prat A, Ha N, Kibria G, Huo D, Zheng H, et al:
MiR-206 inhibits stemness and metastasis of breast cancer by
targeting MKL1/IL11 pathway. Clin Cancer Res. 23:1091–1103. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chaudhary B, Khaled YS, Ammori BJ and
Elkord E: Neuropilin 1: Function and therapeutic potential in
cancer. Cancer Immunol Immunother. 63:81–99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen C, Hu Y and Li L: NRP1 is targeted by
miR-130a and miR-130b, and is associated with multidrug resistance
in epithelial ovarian cancer based on integrated gene network
analysis. Mol Med Rep. 13:188–196. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
MicroRNA-338 inhibits growth, invasion and metastasis of gastric
cancer by targeting NRP1 expression. PLoS One. 9:e944222014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ma L, Zhai B, Zhu H, Li W, Jiang W, Lei L,
Zhang S, Qiao H, Jiang X and Sun X: The miR-141/neuropilin-1 axis
is associated with the clinicopathology and contributes to the
growth and metastasis of pancreatic cancer. Cancer Cell Int.
19:2482019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Seifi-Alan M, Shams R, Bandehpour M,
Mirfakhraie R and Ghafouri-Fard S: Neuropilin-1 expression is
associated with lymph node metastasis in breast cancer tissues.
Cancer Manag Res. 10:1969–1974. 2018. View Article : Google Scholar : PubMed/NCBI
|
